Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features

Background: Pseudoprogression (PsP) mimics true early progression (TeP) in conventional imaging, which poses a diagnostic challenge in glioblastoma (GBM) patients who undergo standard concurrent chemoradiation (CCRT). This study aimed to investigate whether perioperative markers could distinguish an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Li, Mingxiao, Ren, Xiaohui, Dong, Gehong, Wang, Jincheng, Jiang, Haihui, Yang, Chuanwei, Zhao, Xuzhe, Zhu, Qinghui, Cui, Yong, Yu, Kefu, Lin, Song
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8093388/
https://ncbi.nlm.nih.gov/pubmed/33959496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.627325
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars